Atlas Trials

Magnetic Marker Monitoring of Furosemide-containing Gastroretentive Formulation in Healthy Male Subjects (Fasting and Fed Conditions)

Clinical trial NCT01887379 · COMPLETED

Trial details

NCT number
NCT01887379
Sponsor
LTS Lohmann Therapie-Systeme AG
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Gastroretentive Drug Formulation of FurosemideOedema
Start date
2013-06-01
Primary completion
2013-08-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.